Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Earnings Data
Report Date
Mar 11, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.61Last Year’s EPS
-1.27Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented significant positive developments, including strong revenue growth, profitability, and broad payer coverage for VYKAT XR. However, these were tempered by challenges such as increased discontinuation rates and the impact of a short seller report affecting market momentum.Company Guidance
Significant Revenue Growth and Profitability
Total net revenue more than doubled from the second quarter to $66 million, and the company achieved a positive net income of $26 million for the third quarter.
Strong Market Adoption of VYKAT XR
By the end of Q3, 764 individuals were actively treated with VYKAT XR, with 397 patient start forms in the third quarter.
Broad Payer Coverage
Policies cover approximately 132 million lives, including coverage policies with appropriate criteria from the top 3 national PBMs and broad access across commercial, Medicaid, and Medicare channels.
Progress in Regulatory Approval for DCCR in Europe
The company is progressing along regulatory pathways in Europe, responding to day 120 questions from the EMA.
SLNO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SLNO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $63.85 | $46.87 | -26.59% |
Aug 06, 2025 | $81.19 | $78.71 | -3.05% |
May 07, 2025 | $74.66 | $76.26 | +2.14% |
Feb 27, 2025 | $44.99 | $48.82 | +8.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Soleno Therapeutics Inc (SLNO) report earnings?
Soleno Therapeutics Inc (SLNO) is schdueled to report earning on Mar 11, 2026, TBA (Confirmed).
What is Soleno Therapeutics Inc (SLNO) earnings time?
Soleno Therapeutics Inc (SLNO) earnings time is at Mar 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SLNO EPS forecast?
SLNO EPS forecast for the fiscal quarter 2025 (Q4) is 0.61.